Global Spatial Genomics and Transcriptomics Market
Report Scope:
This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Includes:
34 data tables and 30 additional tables
An overview of the global spatial genomics and transcriptomics market
Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
Estimation of the market size and highlights of the market potential by technology, end user, and application
Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry
Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth
Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Companies Mentioned
10X GENOMICS
ADVANCED CELL DIAGNOSTICS INC.
Akoya Biosciences Inc.
BRUKER CORP.
Dovetail Genomics (cantata Bio)
ILLUMINA
Ionpath Inc.
Lunaphore Technologies S.a.
NANOSTRING TECHNOLOGIES
RARECYTE INC.
Standard Biotools Inc.
Vizgen Inc.
- Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing this Study
- 1.3 Scope of Report
- 1.4 Information Sources
- 1.5 Methodology
- 1.6 Geographic Breakdown
- 1.7 Analyst's Credentials
- 1.8 BCC Custom Research
- 1.9 Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Market Overview
- 3.1 Spatial Genomics and Transcriptomics
- 3.1.1 Spatial Genomics
- 3.1.2 Spatial Transcriptomics
- 3.2 Spatial Transcriptomics Technologies
- 3.2.1 Fusion of Multiple Technologies
- 3.2.2 Spatial Genomics and Transcriptomics Provides Balance
- 3.3 Understanding Spatial Biology
- 3.4 Importance of Spatial Biology
- 3.5 Spatial Sequencing
- 3.6 Spatial Biology of Cancer Evolution
- 3.7 Innovation in Medical and Healthcare Products
- 3.8 Current Trends
- 3.8.1 Enhanced Cybersecurity
- 3.8.2 Internet of Medical Things
- 3.8.3 Medical Robots
- 3.8.4 Three-Dimensionally Printed Objects
- 3.8.5 Device Connectivity
- 3.8.6 Implications for Health Systems
- 3.9 Regulations and Legislation
- 3.9.1 Europe
- 3.9.2 U.S.
- 3.9.3 Japan
- Chapter 4 Market Dynamics
- 4.1 Drivers
- 4.1.1 New Discoveries in Biological Sciences
- 4.1.2 Increasing Use of Bioinformatics Analytical Software
- 4.1.3 Antibody-Based Drug Discovery and Development
- 4.1.4 Developed and Increasing Research Areas
- 4.1.5 Application-Focused Technology Platforms
- 4.1.6 Strengthen Use and Adoption of Consumables
- 4.1.7 Increase in Infectious and Chronic Diseases
- 4.1.8 Relationships among Biopharma Firms, Research Institutions and Medical Centers
- 4.2 Restraints
- 4.2.1 Labor-Intensive Technology and Products
- 4.3 Opportunities
- 4.3.1 Human Genome Project Development
- 4.3.2 Coming Revolution of Precision Medicine
- 4.4 Strategies
- 4.4.1 Trends
- Chapter 5 Impact of the COVID-19 Pandemic
- 5.1 Impact of COVID-19 on Pharmaceutical and Biotech Industries
- 5.2 Short-Term Impact
- 5.2.1 Change in Demand
- 5.2.2 Shift of Communication and Promotions to Remote Interactions
- 5.2.3 Changes in R&D
- 5.3 Long-Term Impact
- 5.3.1 Delayed Approvals for Non-COVID-Related Pharmaceutical and Biotech Products
- 5.3.2 Self-Sufficiency in the Pharma and Biotech Industries
- 5.3.3 Pharmaceutical Industry Growth Slowdown
- 5.3.4 Changes in Consumption Trends in Health-Related Products
- 5.3.5 Potential Impact of COVID-19 on Genomic Study
- Chapter 6 Business Model and Innovation
- 6.1 Business Model Innovation
- Chapter 7 Global Spatial Genomics and Transcriptomics: Technology Market
- 7.1 Overview
- 7.2 Spatial Genomics
- 7.2.1 Market Outlook
- 7.3 Spatial Transcriptomics
- 7.3.1 Market Outlook
- Chapter 8 Global Spatial Genomics and Transcriptomics Market by Product
- 8.1 Overview
- 8.2 Market for Spatial Genomics and Transcriptomics, by Product
- 8.3 Market Outlook
- 8.3.1 Consumables
- 8.3.2 Instruments
- 8.3.3 Software
- Chapter 9 Global Spatial Genomics and Transcriptomics Market by Application
- 9.1 Overview
- 9.2 Spatial Genomics and Transcriptomics Market by Application
- 9.3 Market Outlook
- 9.3.1 Clinical and Translational Research
- 9.3.2 Drug Discovery and Development
- Chapter 10 Global Spatial Genomics and Transcriptomics Market by End User
- 10.1 Overview
- 10.2 Market for Spatial Genomics and Transcriptomics by End User
- 10.3 Market Outlook
- 10.3.1 Academic and Research Institutes
- 10.3.2 Contract Research Organizations
- 10.3.3 Pharmaceutical and Biotechnology
- Chapter 11 Global Spatial Genomics and Transcriptomics Market by Region
- 11.1 North America
- 11.1.1 Market Outlook
- 11.2 Europe
- 11.2.1 Market Outlook
- 11.3 Asia-Pacific
- 11.3.1 Market Outlook
- 11.4 Rest of the World
- 11.4.1 Market Outlook
- Chapter 12 Competitive Landscape
- Chapter 13 Company Profiles
- 10X GENOMICS
- ADVANCED CELL DIAGNOSTICS INC.
- AKOYA BIOSCIENCES INC.
- BRUKER CORP.
- DOVETAIL GENOMICS (CANTATA BIO)
- ILLUMINA
- IONPATH INC.
- LUNAPHORE TECHNOLOGIES S.A.
- NANOSTRING TECHNOLOGIES
- RARECYTE INC.
- STANDARD BIOTOOLS INC.
- VIZGEN INC.
- Other Companies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook